Results 251 to 260 of about 234,696 (305)
Some of the next articles are maybe not open access.
Immune Monitoring for CMV in Transplantation
Current Infectious Disease Reports, 2018Michelle K Yong +2 more
exaly +2 more sources
Optometry and Vision Science, 1995
ABSTRACT Background. Cytomegalovirus (CMV) retinitis is the most common ocular opportunistic infection in patients with AIDS. CMV retinitis is often asymptomatic and usually appears when the patient's CD4 lymphocyte levels fall below 50/mm3.
openaire +2 more sources
ABSTRACT Background. Cytomegalovirus (CMV) retinitis is the most common ocular opportunistic infection in patients with AIDS. CMV retinitis is often asymptomatic and usually appears when the patient's CD4 lymphocyte levels fall below 50/mm3.
openaire +2 more sources
Advances in Neonatal Care, 2007
Most infants exposed to cytomegalovirus (CMV) in utero will not be symptomatic; however, infants born with symptomatic CMV will have more severe consequences and poorer prognosis than will asymptomatic infants. The timing of infection during pregnancy largely affects the expected outcomes and consequences to the fetus.
openaire +2 more sources
Most infants exposed to cytomegalovirus (CMV) in utero will not be symptomatic; however, infants born with symptomatic CMV will have more severe consequences and poorer prognosis than will asymptomatic infants. The timing of infection during pregnancy largely affects the expected outcomes and consequences to the fetus.
openaire +2 more sources
Journal of Clinical Virology, 2018
BACKGROUND Assays detecting CMV-specific cell-mediated immunity (CMI) may support the current management of CMV infection in solid-organ transplant (SOT) recipients, by allowing a better risk assessment and adjusting antiviral treatment. OBJECTIVES The
S. Gliga +7 more
semanticscholar +1 more source
BACKGROUND Assays detecting CMV-specific cell-mediated immunity (CMI) may support the current management of CMV infection in solid-organ transplant (SOT) recipients, by allowing a better risk assessment and adjusting antiviral treatment. OBJECTIVES The
S. Gliga +7 more
semanticscholar +1 more source
Late-onset CMV disease following CMV prophylaxis
Irish Journal of Medical Science, 2009Cytomegalovirus (CMV) is the most common opportunistic infection after solid-organ transplantation, increasing morbidity and mortality. Three months of oral valganciclovir have been shown to provide effective prophylaxis. Late-onset CMV disease, occurring after the discontinuation of prophylaxis, is now increasingly recognised.To investigate the ...
C, Donnelly +4 more
openaire +2 more sources
CMV encephalitis during ganciclovir therapy of CMV retinitis
Infection, 1990An AIDS patient with cytomegalovirus (CMV) retinitis was treated with ganciclovir (10 mg/kg) for four days followed by 5 mg/kg for 69 days. Clinically, CMV retinitis improved during therapy. Two weeks after induction of therapy, the patient became increasingly disoriented, and died 78 days after admission.
T F, Schwarz +5 more
openaire +2 more sources
The Hearing Journal, 2013
Exclusively for TheHearingJournal.com AUGUST 2013 After two-year-old Daisy Doutre developed profound bilateral hearing loss from a common herpes virus she had at birth, her grandmother, Utah Rep. Ronda Rudd Menlove, R-Garland, took steps to raise public awareness of one of the leading causes of hearing loss in children. Rep.
openaire +2 more sources
Exclusively for TheHearingJournal.com AUGUST 2013 After two-year-old Daisy Doutre developed profound bilateral hearing loss from a common herpes virus she had at birth, her grandmother, Utah Rep. Ronda Rudd Menlove, R-Garland, took steps to raise public awareness of one of the leading causes of hearing loss in children. Rep.
openaire +2 more sources
Transplantation, 2023
Background. Prevention of cytomegalovirus (CMV) infection after kidney transplantation is costly and burdensome. Methods. Given its promising utility in risk stratification, we evaluated the use of QuantiFERON-CMV (QFCMV) and additional clinical variables in this prospective cohort ...
José O, Reusing +5 more
openaire +2 more sources
Background. Prevention of cytomegalovirus (CMV) infection after kidney transplantation is costly and burdensome. Methods. Given its promising utility in risk stratification, we evaluated the use of QuantiFERON-CMV (QFCMV) and additional clinical variables in this prospective cohort ...
José O, Reusing +5 more
openaire +2 more sources
Transplant Immunology, 2018
Cytomegalovirus (CMV)-specific T-cells are crucial to prevent CMV disease. CMV seropositive recipients transplanted with stem cells from a CMV seronegative allogeneic donor (R+D-) may be at risk for CMV disease due to absence of donor CMV-specific memory T-cells in the graft.We analyzed the duration of CMV reactivations and the incidence of CMV disease
Heiden, P.L.J. van der +9 more
openaire +3 more sources
Cytomegalovirus (CMV)-specific T-cells are crucial to prevent CMV disease. CMV seropositive recipients transplanted with stem cells from a CMV seronegative allogeneic donor (R+D-) may be at risk for CMV disease due to absence of donor CMV-specific memory T-cells in the graft.We analyzed the duration of CMV reactivations and the incidence of CMV disease
Heiden, P.L.J. van der +9 more
openaire +3 more sources